Tygh Capital Management’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	$2.85M	Sell	48,675 -98	-0.2%	-$5.73K	0.36%	74
2021 Q3	$2.89M	Buy	48,773 +12,358	+34%	+$733K	0.39%	80
2021 Q2	$3.16M	Sell	36,415 -388	-1%	-$33.7K	0.43%	79
2021 Q1	$3.03M	Buy	36,803 +1,467	+4%	+$121K	0.43%	79
2020 Q4	$3.21M	Buy	+35,336	New	+$3.21M	0.5%	76